Amicus Therapeutics Investor Presentation 2017

Form 8-K filing containing two investor presentation decks from Amicus Therapeutics for February 2017 meetings with investors and analysts. Materials cover corporate overview and Pompe disease therapeutic approach, detailing the company's product pipeline and market strategy.